Imiquimod
Back to searchMolecule Structure
Scientific Name
Imiquimod
Description of the Drug
Imiquimod is a toll-like receptor 7 agonist used to treat non hyperkeratotic, non hypertrophic actinic keratosis, basal cell carcinoma, genital or perianal warts, and condyloma acuminata.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00724
http://www.drugbank.ca/drugs/DB00724
Brand Name(s)
Aldara, Imiquimod, Zyclara
Company Owner(s)
Apotex Inc, Glenmark Generics Inc Usa, Fougera Pharmaceuticals Inc, Anda Repository Llc, Padagis Israel Pharmaceuticals Ltd, Taro Pharmaceutical Industries Ltd, Strides Pharma Global Pte Ltd, Cosette Pharmaceuticals Inc, Bausch Health Us Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Toll-like receptor 7 | SINGLE PROTEIN | AGONIST | CHEMBL5936 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL26136 | ||
PharmGKB | PA449972 | ||
Human Metabolome Database | HMDB0014862 | ||
DrugBank | DB00724 | ||
PubChem: Thomson Pharma | 14749564 | ||
PubChem | 57469 | ||
Mcule | MCULE-9421195760 | ||
LINCS | LSM-5408 | ||
Nikkaji | J501.447F | ||
PDBe | 6T0 | ||
BindingDB | 50240849 | ||
EPA CompTox Dashboard | DTXSID7041047 | ||
DrugCentral | 1429 | ||
ChemicalBook | CB9257146 | CB2664655 | |
Guide to Pharmacology | 5003 | ||
rxnorm | ALDARA | IMIQUIMOD | ZYCLARA |
PubChem: Drugs of the Future | 12013659 | ||
ChEBI | 36704 | ||
ZINC | ZINC000019632912 |